Recombinant Schizosaccharomyces pombe Uncharacterized mitochondrial carrier C29A3.11c (SPBC29A3.11c)

Advanced Research Questions

• What experimental approaches are recommended for determining SPBC29A3.11c function?

  Multiple complementary approaches should be employed to determine the function of this uncharacterized carrier:

  1. Gene deletion and phenotypic analysis: Create a ΔSPBC29A3.11c strain and assess growth under various conditions (different carbon sources, stress conditions) .

  2. Localization confirmation: Use GFP or epitope tagging to confirm mitochondrial localization and submitochondrial distribution .

  3. Transport assays: Reconstitute the purified recombinant protein into liposomes to measure transport of potential substrates.

  4. Metabolomic profiling: Compare metabolite levels in wild-type and ΔSPBC29A3.11c strains to identify accumulated or depleted metabolites.

  5. Suppressor screens: Identify genetic suppressors of phenotypes associated with SPBC29A3.11c deletion.

  6. Comparative analysis: Study the effects of deleting similar carriers (like SPAC19G12.05) to identify potential functional overlap .

• How can researchers study the interaction partners of SPBC29A3.11c?

  To identify interaction partners of SPBC29A3.11c, implement the following complementary strategies:

  1. Affinity purification-mass spectrometry (AP-MS): Tag SPBC29A3.11c with epitopes (e.g., TAP-tag, FLAG, or Myc) and purify protein complexes under native conditions. This approach has been successfully used for other mitochondrial proteins in S. pombe .

  2. Proximity labeling: Use BioID or APEX2 fused to SPBC29A3.11c to label proximal proteins in the mitochondrial environment.

  3. Yeast two-hybrid screening: Although challenging for membrane proteins, modified membrane yeast two-hybrid systems can be used.

  4. Co-immunoprecipitation validation: Confirm specific interactions identified through other methods.

  5. Genetic interaction screens: Conduct synthetic genetic array (SGA) analysis to identify genes whose deletion enhances or suppresses phenotypes of SPBC29A3.11c deletion .

  Proteomic studies have previously shown that mitochondrial proteins often co-purify with subsets of mitoribosomal proteins, as observed with Ppr10 and Mpa1 .

• What is the relevance of SPBC29A3.11c to mitochondrial translation?

  While SPBC29A3.11c's direct role in mitochondrial translation is unknown, research on other S. pombe mitochondrial proteins provides context:

  1. Mitochondrial carriers may influence translation by transporting metabolites needed for protein synthesis.

  2. Some mitochondrial proteins, like Ppr10 and Mpa1, function together to mediate mitochondrial translational initiation in S. pombe .

  3. Disruption of mitochondrial carriers can impair association of mitochondrial mRNAs (like cob1 and cox1) with assembled mitochondrial ribosomes .

  4. The association of translational initiation factors Mti2 and Mti3 with the mitochondrial small subunit (mt-SSU) can be affected by disruption of other mitochondrial proteins .

  To investigate potential roles in translation, researchers should examine:

  • Changes in mitochondrial protein synthesis in ΔSPBC29A3.11c strains

  • Association of mitochondrial mRNAs with ribosomes

  • Interactions with known translation factors

• How does SPBC29A3.11c compare to other mitochondrial carriers in S. pombe?

  S. pombe contains multiple mitochondrial carriers with various functions. Comparative analysis reveals:

  Carrier Protein	Systematic Name	Predicted Function	Essential	Phenotype When Deleted
  SPBC29A3.11c	SPBC29A3.11c	Uncharacterized	No	Not fully characterized
  SPAC19G12.05	SPAC19G12.05	Mitochondrial citrate transporter (predicted)	No	Not fully characterized
  Anc1	-	ADP/ATP carrier	Yes	-
  Pet801	-	S-adenosylmethionine transporter	No	Respiratory deficient

  Unlike carriers with established functions, SPBC29A3.11c and similar uncharacterized carriers present research opportunities for novel metabolic pathway discovery .

• What approaches should be used to characterize respiratory phenotypes in SPBC29A3.11c mutants?

  To thoroughly characterize respiratory phenotypes in SPBC29A3.11c deletion mutants:

  1. Growth assays on different carbon sources: Compare growth on fermentable (glucose) versus non-fermentable (glycerol, ethanol) carbon sources. Respiratory-deficient mutants typically show impaired growth on non-fermentable media .

  2. Oxygen consumption measurements: Use a respirometer to measure oxygen consumption rates in intact cells and isolated mitochondria.

  3. Mitochondrial membrane potential assessment: Use fluorescent dyes (JC-1, TMRM) to assess changes in membrane potential.

  4. Respiratory complex activity assays: Measure the activities of individual respiratory chain complexes in isolated mitochondria.

  5. ROS production measurement: Assess reactive oxygen species levels using fluorescent indicators.

  6. mtDNA stability analysis: Check for mtDNA loss or mutations, especially in genes encoding respiratory complex subunits.

  Researchers studying mitochondrial function in S. pombe have successfully used these approaches to characterize phenotypes of deletion mutants under varying nutrient conditions .

• How can researchers develop a reliable in vitro transport assay for SPBC29A3.11c?

  Developing a reliable in vitro transport assay requires:

  1. Protein expression and purification: Express recombinant SPBC29A3.11c in E. coli, yeast, or insect cells with appropriate affinity tags. Purify using methods optimized for membrane proteins (detergent solubilization followed by affinity chromatography) .

  2. Liposome reconstitution: Incorporate purified protein into liposomes with defined lipid composition mimicking the mitochondrial inner membrane.

  3. Substrate identification strategy:

     • Begin with common mitochondrial carrier substrates (nucleotides, metabolites, cofactors)

     • Perform comparative sequence analysis with characterized carriers to predict substrates

     • Use metabolomic analysis of deletion mutants to identify candidate substrates

  4. Transport measurement techniques:

     • Radiolabeled substrate uptake assays

     • Fluorescence-based transport assays

     • Counterflow assays for exchange transporters

  5. Kinetic characterization: Determine Km, Vmax, inhibition patterns, and substrate specificity to fully characterize transport properties.

• What are the recommended approaches for analyzing the effects of SPBC29A3.11c deletion on the mitochondrial proteome?

  To comprehensively analyze the impact of SPBC29A3.11c deletion on the mitochondrial proteome:

  1. Quantitative mitochondrial proteomics:

     • Isolate highly purified mitochondria from wild-type and ΔSPBC29A3.11c strains

     • Use SILAC, TMT, or label-free quantification approaches

     • Apply multidimensional prefractionation techniques (IEF, ion-exchange chromatography) to increase proteome coverage

  2. Analysis of protein complexes:

     • Blue native PAGE to examine respiratory complexes and other mitochondrial complexes

     • Sucrose gradient sedimentation to analyze ribosome assembly and other large complexes

  3. Post-translational modification analysis:

     • Phosphoproteomics to identify changes in signaling

     • Acetylome analysis for metabolic regulation

  4. Targeted analysis of key pathways:

     • Western blotting for selected marker proteins

     • Enzymatic activity assays for respiratory complexes

  Previous proteomics studies in S. pombe achieved identification of ~2000 proteins, including mitochondrial carriers and ribosomal proteins, using multidimensional prefractionation .

• How can researchers integrate SPBC29A3.11c research with broader studies of mitochondrial function in S. pombe?

  Integration strategies should include:

  1. Comparative genomics: Analyze conservation patterns of SPBC29A3.11c across fungi and potentially other eukaryotes to predict functional importance .

  2. Network analysis: Place SPBC29A3.11c in the context of known mitochondrial functional networks using existing protein-protein interaction and genetic interaction data.

  3. Multi-omics integration: Combine proteomics, transcriptomics, and metabolomics data to build a comprehensive model of SPBC29A3.11c function .

  4. Comparative mutant phenotyping: Compare phenotypes of SPBC29A3.11c deletion with other mitochondrial carrier deletions under various growth conditions .

  5. Drug sensitivity profiling: Test sensitivity to antifungals targeting ergosterol biosynthesis and other compounds affecting mitochondrial function .

  6. Collaboration with complementary model systems: Compare findings with studies of related carriers in S. cerevisiae or other fungi.

  Such integrated approaches have successfully elucidated functions of previously uncharacterized mitochondrial proteins in S. pombe, as demonstrated in studies of mitochondrial translation factors and RNA processing enzymes .